Navigation Links
ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering
Date:11/7/2007

FREMONT, Calif., Nov. 7 /PRNewswire-FirstCall/ -- ARYx Therapeutics, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of its common stock at a price of $10.00 per share. All shares are being offered by ARYx Therapeutics. In addition, ARYx Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares to cover over-allotments, if any. ARYx Therapeutics common stock will trade on the NASDAQ Global Market under the symbol "ARYX."

The underwriters of this offering are Morgan Stanley & Co. Incorporated acting as sole book runner and lead manager, and CIBC World Markets Corp., Jefferies & Company, Inc. and Leerink Swann LLC, Inc. acting as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 7, 2007. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated by emailing prospectus@morganstanley.com or by contacting the prospectus department at 180 Varick Street, New York, NY 10014, Attn: Prospectus Department.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation, or sale would be unlawful prior to their registration or qualification under the securities laws of any such state.

About ARYx Therapeutics Inc.

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurall
'/>"/>

SOURCE ARYx Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... have made great strides in saving China,s endangered national ... over 65 giant panda reserves that have been established ... just 1596 pandas remain in the wild. , ... save the panda by improving genetic diversity, avoid inbreeding ... how are these high-profile programs doing so far? , ...
(Date:7/23/2014)... LOS ANGELES , July 23, 2014 /PRNewswire-iReach/ -- ... enhance cognitive performance for the long term. They are ... competitive edge of sustained energy as an alternative to ... launch Think Drinks on Indiegogo on July 29, 2014, ... the 30-day campaign. Photo - http://photos.prnewswire.com/prnh/20140723/129697 ...
(Date:7/23/2014)... Last year, Formedix celebrated ... global provider of data management solutions for clinical trials. ... system for electronic data capture (EDC) and clinical data ... study execution tools added TrialMaster to its Transform for ... of Transform for TrialMaster, is being released this week, ...
(Date:7/23/2014)... StemGenex® , the leading resource for ... at improving the lives of patients dealing with degenerative ... disease. StemGenex believes that a commitment to the ... when providing care to patients with degenerative diseases. ... accessible to the millions of individuals currently living with ...
Breaking Biology Technology:truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3
... 15 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: AOB ), ("the Company" or "AOBO"), ... prescription and over the counter ("OTC"),products, today announced financial results for the fourth quarter and fiscal,year ... ... ...
... ... and material testing, is taking strides to expand their Product and Material Testing Division by ... ... device package, product and material testing, is taking strides to expand their Product and Material ...
... that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL ... ... , , ... ...
Cached Biology Technology:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 2American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 3American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 4American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 5American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 6American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 7American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 8American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 9American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 10American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 11American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results 12DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... sake brewery has its own microbial terroir, meaning the ... those found in the product, creating the final flavor ... journal Applied and Environmental Microbiology . This is ... of a sake brewery. , Many sake makers ... David A. Mills of the University of California, Davis, ...
(Date:7/24/2014)... this week for an all-day public forum on a ... (EPA) to dredge toxic sediment from an eight-mile stretch ... called the plan, which proposes removing 4.3 million cubic ... riverbed, one of the largest cleanups in the agency,s ... off-site. , "We need to ensure the future well-being ...
Breaking Biology News(10 mins):The microbes make the sake brewery 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2
... mandate communitywide water conservation measures, individualsparticularly homeownerscan make ... Hoping to provide urban planners with more information ... supplies, a team from New Mexico State University ... toward high desert plants. Rolston St. Hilaire, Dawn ...
... The Federation of American Societies for Experimental Biology (FASEB) ... the travel award recipients for the 2010 Society for ... Annual Meeting in Anaheim, California from September 30 ... promote the entry of underrepresented minority students, postdoctorates and ...
... Bethesda, MD FASEB MARC (Minority Access to Research ... the 2010 Societ Italiana di Patologia (SIP) XXX National ... These awards are meant to promote the entry of ... of the basic science community and to encourage the ...
Cached Biology News:Santa Fe homeowners weigh in on landscape preferences 2MARC Travel Awards announced for the 2010 SACNAS Annual Meeting 2
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
Fetal Calf Serum Replacement (Bistec) serum...
... reagent for Virus isolation ... unique water insoluble Elastomeric ... and chaotropes; Engineered to ... viruses while preserving infectivity; ...
Non-Receptor Tyrosine Kinase Sampler Kit 10 mu g each...
Biology Products: